期刊： HEPATOLOGY INTERNATIONAL, 2022; 16 (3)
Background To establish and validate a radiomics-based model for staging liver fibrosis at contrast-enhanced CT images. Materials and methods This ret......
期刊： HEPATOLOGY INTERNATIONAL, 2022; 16 (3)
Background There is a growing need for new improved classifiers of prognosis in hepatocellular carcinoma (HCC) patients to stratify them effectively. ......
期刊： HEPATOLOGY INTERNATIONAL, 2022; 16 (1)
Background Primary liver cancer has high mortality and morbidity worldwide. However, the characteristic of gut microbiota profile and its correlation ......
期刊： HEPATOLOGY INTERNATIONAL, 2022; 16 (4)
Background/purpose of the study Mortality from hepatitis B virus (HBV)-related acute-on-chronic liver failure (ACLF) is high. Severe infection is the ......
期刊： HEPATOLOGY INTERNATIONAL, 2022; 16 (5)
Background Metabolic associated fatty liver disease (MAFLD) is the most common chronic liver disease worldwide. The important role of urid acid (UA) i......
期刊： HEPATOLOGY INTERNATIONAL, 2022; 16 (1)
Background and aims Gamma-delta (gamma delta) T cells are involved in the development of diverse liver and autoimmune diseases, whereas the role of ga......
期刊： HEPATOLOGY INTERNATIONAL, 2022; 16 (1)
Background Non-alcoholic steatohepatitis (NASH) is a progression of non-alcoholic fatty liver disease. The increasing burden of NASH has become a majo......
期刊： HEPATOLOGY INTERNATIONAL, 2022; 16 (3)
Background Data on safety and immunogenicity of coronavirus disease 2019 (COVID-19) vaccination in patients with compensated (C-cirrhosis) and decompe......
期刊： HEPATOLOGY INTERNATIONAL, 2022; 16 (4)
Background and aims This study aimed to establish a non-invasive model based on the virtual portal pressure gradient (vPPG) to predict the first varic......
期刊： HEPATOLOGY INTERNATIONAL, 2022; 16 (4)
Purpose To analyze the long-term oncological outcomes of Barcelona Clinic Liver Cancer (BCLC) stages 0-A hepatocellular carcinoma (HCC) patients assoc......
期刊： HEPATOLOGY INTERNATIONAL, 2022; 16 (4)
Background The optimal locoregional treatment for hepatocellular carcinoma (HCC) patients with portal vein tumor thrombus (PVTT) is unclear. This stud......
期刊： HEPATOLOGY INTERNATIONAL, 2022; 16 (5)
Background Hepatocellular carcinoma (HCC) is an aggressive carcinoma with genome instability. Long non-coding RNAs (LncRNAs) have been functionally as......
